Catalyst
Slingshot members are tracking this event:
Phase 1 data of TRC105 + Opdivo in Non-small cell lung cancer (NSCLC) to be presented at IASLC 2019 February 20-23
- Source Link:
- http://ir.traconpharma.com/node/9556/html
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TCON | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 22, 2019
Occurred Source:
http://ir.traconpharma.com/news-releases/news-release-details/tracon-pharmaceuticals-announces-positive-data-ongoing-phase-0
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Trc105, Opdivo, Non-small Cell Lung Cancer
